Keywords: Nanotechnology; Nanoparticles; Retina; Vitreous; Sustained release; AMDCyclosporine A; Difluprednate; Aflibercept; Bevacizumab; Pegaptanib; Ranibizumab
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Comparison of choroidal and retinal endothelial cells: Characteristics and response to VEGF isoforms and anti-VEGF treatments
Keywords: age-related macular degeneration; ocular neovascularisation; endothelial cell; ranibizumab; bevacizumab; pegaptanib; retina; choroidhCEC, human choroidal endothelial cell; hREC, human retinal endothelial cell; VEGFR1, VEGF receptor 1; VEGRF2, VEGF recepto
The role of different VEGF isoforms in scar formation after glaucoma filtration surgery
Keywords: vascular endothelial growth factor; pegaptanib; Tenon fibroblasts; human umbilical vein endothelial cells; glaucoma filtration surgery; wound healingVEGF, vascular endothelial growth factor; VEGF-R2, VEGF receptor 2; NRP-1, neuropilin-1; HSPGs, heparin su
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Keywords: bevacizumab; ocular neovascular diseases; pegaptanib; ranibizumab; safety; vascular endothelial growth factor inhibitor
Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma
Keywords: Anti-angiogenesis; Pegaptanib; Irradiation; Orthotopic; Glioma
La dégénérescence maculaire liée à l’âge
Keywords: Dégénérescence maculaire liée à l’âge; Angiographie; Tomographie en cohérence optique; Photocoagulation laser; Photothérapie dynamique; Pegaptanib; RanibizumabAge-related macular degeneration; Angiography; Optical coherence tomography; Laser photocoagulat
Pegaptanib for the treatment of age-related macular degeneration
Keywords: pegaptanib; neovascular age-related macular degeneration; vascular endothelial growth factor; VEGF165; aptamer
Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration
Keywords: age factor; choroidal neovascularization; low vision; macular degeneration; pegaptanib; treatment delays;
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration
Keywords: age factor; anecortave; antiangiogenesis; macular degeneration; pegaptanib; ranibizumab; triamcinolone acetonide; vascular endothelial growth factor;